19.07.2018 • News

Bain to Buy Italmatch Chemicals

Bain to Buy Italmatch Chemicals
Bain to Buy Italmatch Chemicals

US private equity group Bain Capital has agreed to buy Italmatch Chemicals from French investment house Ardian for an undisclosed sum.

Headquartered in Genoa, Italy, Italmatch manufactures specialty chemical additives and operates four business units: Water & Oil Treatment; Lubricants, Flame Retardants & Plastic Additives; and Performance Products & Personal Care.

Under Ardian’s four-year ownership, the Italian group has more than doubled its sales, both organically and through multiple acquisitions. The acquisitions included Afton Chemical’s metalworking fluid business, Jiayou Chemical, Detrex, Sudamfos do Brasil, Magpie Polymers, Compass Chemical International, Solvay’s desalination and phosphonates and phosphonic acid-based water additives business, and GRS Chemical Technologies.

Bain Capital’s managing director, Ivano Sessa, said it looked forward to supporting Italmatch’s management to continue growing the company, both organically and through an “ambitious plan of strategic acquisitions”.

Italmatch employs 780 staff at sites around the world and posted sales of around €400 million in 2017. The company operates seven plants in Europe (Italy, Spain, Germany and the UK), five in Asia (China, Japan and India), and five in the US. It also has sales and distribution subsidiaries in Brazil, Belgium, China, Japan, India, Poland, Singapore and USA.

Interview

Driving Sustainability Through Collaboration
Building Green Practices Across the Chemical Supply Chain

Driving Sustainability Through Collaboration

Together for Sustainability (TfS) is a pioneering, member-led initiative working to accelerate sustainable and resilient chemical supply chains. TfS President Jennifer Jewson discusses the origins of TfS, its evolving goals, its present-day challenges, and the initiative’s enduring impact and outlook for the future.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.